Identification of new therapeutic targets in CRLF2-overexpressing B-ALL through discovery of2 TF-gene regulatory interactions.
Sana Badri, Beth A. Carella, Priscillia Lhoumaud, Dayanne M. Castro, Claudia Skok Gibbs, Ramya Raviram, Sonali Narang, Nikki Ann Evensen, Aaron Watters, William L. Carroll, Richard Bonneau, Jane A. Skok
The paper identifies new therapeutic targets in CRLF2-overexpressing B-ALL by analyzing TF-gene regulatory interactions using network inference and experimental validation.
bioRxiv · Sep 26, 2020 · PreprintGenomics